0001354488-14-004534.txt : 20140908 0001354488-14-004534.hdr.sgml : 20140908 20140908165122 ACCESSION NUMBER: 0001354488-14-004534 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140903 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20140908 DATE AS OF CHANGE: 20140908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WOUND MANAGEMENT TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0000714256 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 592220004 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11808 FILM NUMBER: 141091481 BUSINESS ADDRESS: STREET 1: 777 MAIN STREET STREET 2: SUITE 3100 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817-820-7080 MAIL ADDRESS: STREET 1: 777 MAIN STREET STREET 2: SUITE 3100 CITY: FORT WORTH STATE: TX ZIP: 76102 FORMER COMPANY: FORMER CONFORMED NAME: MB SOFTWARE CORP DATE OF NAME CHANGE: 19960805 FORMER COMPANY: FORMER CONFORMED NAME: INAV TRAVEL CORPORATION DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TWISTEE TREAT CORP DATE OF NAME CHANGE: 19910220 8-K 1 wndm_8k.htm CURRENT REPORT wndm_8k.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): September 3, 2014
 
 
  Wound Management Technologies, Inc.  
  (Exact name of registrant as specified in its charter)  
     
Texas 000-11808 59-2219994
(State or other jurisdiction (Commission File (IRS Employer
 incorporation)  Number) Identification No.)
     
  16633 Dallas Parkway, Suite 250, Addison, Texas 75001    
   (Address of principal executive offices) (Zip Code)   
     
Registrant’s telephone number, including area code   972-218-0935   
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[_]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[_]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[_]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 

Item 5.07 Submission of Matters to a Vote of Security Holders
 
(a)  
On September 3, 2014, Wound Management Technologies, Inc. (the “Company”) held its Annual Meeting of Stockholders.
 
(b)  
The following table presents the final voting results for the items that were presented for stockholder approval.
 
   
For
    
Against
    
Abstain
    
Broker Non-vote
  
(1) To elect to the Wound Management Board of Directors until the next annual meeting of shareholders:
 
                        
Robert Lutz, Jr.
     94,434,032       2,248,382       20,005       26,539,582  
Philip J. Rubinfeld
     88,181,134       8,501,281       20,005       26,539,582  
John Feltman
     88,191,134       8,491,280       20,005       26,539,582  
Ronald Goode
     94,441,128       2,241,286       20,005       26,539,582  
Jeff Lewis
     94,441,133       2,241,281       20,005       26,539,582  
(2) To ratify the appointment of Malone Bailey LLP as Wound Management’s independent registered public accounting firm for the year ending December 31, 2014.
     119,304,468       11,627       91,747    
__
  
(3) To adopt an amendment to the Company’s Articles of Incorporation to increase the authorized shares of common stock of the Company from 100,000,000 to 250,000,000.
     113,780,945       3,746,432       602,015       5,507,648  
(4) To authorize the filing, within the next twelve months of an additional amendment to the Company’s Articles of Incorporation effecting a 1-for-10 reverse split of the Company’s common stock.
     113,040,722       6,367,106       12       4,229,200  
(5) To approve the adoption of the Company’s 2014 Stock Incentive Plan.
     87,582,806       9,119,609       4       26,539,582  
(6) To approve, by advisory vote, a resolution on executive compensation.
     87,925,407       8,777,008       4       26,539,582  
                                 
   
One Year
    
Two Years
    
Three Years
    
Abstain
  
(7) Recommend, by advisory vote, the frequency of future advisory votes on executive compensation.
     4,596,043       6,735,453       82,400,561       2,963,855  
 
Based on the voting as reported above, the director nominees named above were elected as a director of the Company until the next annual meeting of shareholders. In addition, the Company’s shareholders ratified the appointment of Malone Bailey LLP; approved the Charter Amendment; authorized the Reverse Split Amendment; approved the 2014 Stock Plan; approved, by advisory vote, a resolution on executive compensation; and recommended, by advisory vote, a three-year frequency of future advisory votes on executive compensation.
 
In light of these results, the Company’s Board of Directors has decided that future advisory votes on named executive officer compensation will be held every three years until the next advisory vote on the frequency of such votes, which in accordance with applicable law, will occur no later than the Company’s Annual Meeting in 2020.

 
 
2
 


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  WOUND MANAGEMENT TECHNOLOGIES, INC.  
       
Date: September 8, 2014
By:
/s/ Darren Stine, Chief Financial Officer  
   
Darren Stine, Chief Financial Officer
  
       
       

 
 
3